You are here: Home » News-IANS » Health-Medicine
Business Standard

Dr Reddy's to sell Progesterone capsules in US

IANS  |  Hyderabad 

Indian drug major Dr Reddy's Laboratories on Friday announced it would sell Progesterone capsules in the US market for therapeutic treatment of cardiovascular disorders, breast and probable dementia.

"The generic capsules, approved by the US Food and Drug Administration (USFDA), are a therapeutic equivalent version of Prometrium," said the city-based pharma company in a regulatory filing on the BSE.

Prometrium is a registered trademark of Abbvie Products LLC in the US.

"The capsules in 100mg and 200mg will be sold in bottle count size of 100," added the filing.

According to the healthcare industry information, services and technology provider IMS Health, the Prometrium brand and its generic capsules had sales valued at $153 million across the US in 12 months ending February.

--IANS

fb/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Dr Reddy's to sell Progesterone capsules in US

Indian drug major Dr Reddy's Laboratories on Friday announced it would sell Progesterone capsules in the US market for therapeutic treatment of cardiovascular disorders, breast cancer and probable dementia.

Indian drug major Dr Reddy's Laboratories on Friday announced it would sell Progesterone capsules in the US market for therapeutic treatment of cardiovascular disorders, breast and probable dementia.

"The generic capsules, approved by the US Food and Drug Administration (USFDA), are a therapeutic equivalent version of Prometrium," said the city-based pharma company in a regulatory filing on the BSE.

Prometrium is a registered trademark of Abbvie Products LLC in the US.

"The capsules in 100mg and 200mg will be sold in bottle count size of 100," added the filing.

According to the healthcare industry information, services and technology provider IMS Health, the Prometrium brand and its generic capsules had sales valued at $153 million across the US in 12 months ending February.

--IANS

fb/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Dr Reddy's to sell Progesterone capsules in US

Indian drug major Dr Reddy's Laboratories on Friday announced it would sell Progesterone capsules in the US market for therapeutic treatment of cardiovascular disorders, breast and probable dementia.

"The generic capsules, approved by the US Food and Drug Administration (USFDA), are a therapeutic equivalent version of Prometrium," said the city-based pharma company in a regulatory filing on the BSE.

Prometrium is a registered trademark of Abbvie Products LLC in the US.

"The capsules in 100mg and 200mg will be sold in bottle count size of 100," added the filing.

According to the healthcare industry information, services and technology provider IMS Health, the Prometrium brand and its generic capsules had sales valued at $153 million across the US in 12 months ending February.

--IANS

fb/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22